Denali Therapeutics (NASDAQ:DNLI) announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for tividenofusp alfa for…
designer491/iStock via Getty Images Stoke Therapeutics (NASDAQ:STOK) announced alignment with global regulatory agencies on the design of the company’s Phase…
